Gilead Slaps Rivals With Patent Suit Over HIV Drug
By Jasmin Boyce · May 10, 2022, 5:02 PM EDT
Gilead Sciences Inc. has initiated a drug patent suit against a trio of competitors in Delaware federal court, seeking to block three generic versions of its human immunodeficiency virus treatment Biktarvy....
To view the full article, register now.